MX353134B - Ratones con receptor de linfocitos t modificados geneticamente. - Google Patents

Ratones con receptor de linfocitos t modificados geneticamente.

Info

Publication number
MX353134B
MX353134B MX2014004894A MX2014004894A MX353134B MX 353134 B MX353134 B MX 353134B MX 2014004894 A MX2014004894 A MX 2014004894A MX 2014004894 A MX2014004894 A MX 2014004894A MX 353134 B MX353134 B MX 353134B
Authority
MX
Mexico
Prior art keywords
genetically modified
cell receptor
human animal
receptor mice
making
Prior art date
Application number
MX2014004894A
Other languages
English (en)
Other versions
MX2014004894A (es
Inventor
J Murphy Andrew
Stevens Sean
Macdonald Lynn
Mcwhirter John
Tu Naxin
Voronina Vera
Gurer Cagan
Meagher Karolina
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2014004894A publication Critical patent/MX2014004894A/es
Publication of MX353134B publication Critical patent/MX353134B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un animal no humano modificado genéticamente que comprende en su genoma los loci del gen variable de receptor de linfocitos T no rearreglado así como embriones no humanos, células y tejidos que comprenden a los mismos. También se proporcionan construcciones para producir a los animales no humanos modificados genéticamente y métodos para elaboración de los mismos. También se proporcionan diversos métodos de uso de los animales no humanos modificados genéticamente.
MX2014004894A 2011-10-28 2012-10-26 Ratones con receptor de linfocitos t modificados geneticamente. MX353134B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US201261621198P 2012-04-06 2012-04-06
US201261700908P 2012-09-14 2012-09-14
PCT/US2012/062065 WO2013063361A1 (en) 2011-10-28 2012-10-26 Genetically modified t cell receptor mice

Publications (2)

Publication Number Publication Date
MX2014004894A MX2014004894A (es) 2014-09-12
MX353134B true MX353134B (es) 2017-12-20

Family

ID=47178340

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012602A MX379517B (es) 2011-10-28 2012-10-26 Ratones con receptor de linfocitos t modificados genéticamente.
MX2014004894A MX353134B (es) 2011-10-28 2012-10-26 Ratones con receptor de linfocitos t modificados geneticamente.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017012602A MX379517B (es) 2011-10-28 2012-10-26 Ratones con receptor de linfocitos t modificados genéticamente.

Country Status (25)

Country Link
US (3) US9113616B2 (es)
EP (3) EP3795587A1 (es)
JP (7) JP6254528B2 (es)
KR (5) KR101964776B1 (es)
CN (5) CN114891797A (es)
AU (5) AU2012327204B2 (es)
BR (1) BR112014009203B1 (es)
CA (1) CA2853707A1 (es)
CY (2) CY1120945T1 (es)
DK (2) DK3424947T3 (es)
ES (2) ES2691475T3 (es)
HR (2) HRP20181626T1 (es)
HU (1) HUE053444T2 (es)
IL (4) IL274914B2 (es)
IN (1) IN2014CN03890A (es)
LT (2) LT3424947T (es)
MX (2) MX379517B (es)
PL (2) PL2771357T3 (es)
PT (2) PT2771357T (es)
RS (2) RS57893B1 (es)
RU (1) RU2661106C2 (es)
SG (2) SG11201401030WA (es)
SI (2) SI3424947T1 (es)
SM (2) SMT202100243T1 (es)
WO (1) WO2013063361A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114891797A (zh) * 2011-10-28 2022-08-12 瑞泽恩制药公司 T细胞受体基因修饰小鼠
CN103212064B (zh) * 2012-01-19 2016-02-17 中国科学院上海巴斯德研究所 磷酸化途径相关因子在调控调节性t细胞功能中的应用
CN104364380B (zh) 2012-04-25 2018-10-09 瑞泽恩制药公司 核酸酶介导的使用大靶向载体的靶向
GB2508414A (en) * 2012-11-30 2014-06-04 Max Delbrueck Centrum Tumour specific T cell receptors (TCRs)
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CA2908697C (en) 2013-04-16 2023-12-12 Regeneron Pharmaceuticals, Inc. Targeted modification of rat genome
SG10201700961TA (en) 2013-12-11 2017-04-27 Regeneron Pharma Methods and compositions for the targeted modification of a genome
TWI681969B (zh) * 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
HUE049776T2 (hu) * 2014-06-06 2020-10-28 Regeneron Pharma Módszerek és készítmények egy célzott lókusz módosítására
HUE048677T2 (hu) * 2014-06-19 2020-07-28 Regeneron Pharma Humanizált programozott sejthalál 1 génnel rendelkezõ nem-humán állatok
EP3161128B1 (en) 2014-06-26 2018-09-26 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
WO2016044745A1 (en) * 2014-09-19 2016-03-24 Regeneron Pharmaceuticals, Inc. Chimeric antigen receptors
EP3221457B1 (en) 2014-11-21 2019-03-20 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modification using paired guide rnas
KR20240055876A (ko) * 2014-11-24 2024-04-29 리제너론 파마슈티칼스 인코포레이티드 인간화 cd3 복합체를 발현하는 비인간 동물
JP6840077B2 (ja) 2014-12-19 2021-03-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 単一ステップの複数標的化を通じた標的化された遺伝子修飾のための方法及び組成物
KR20240132525A (ko) * 2015-04-06 2024-09-03 리제너론 파아마슈티컬스, 인크. 비인간 동물에서의 인간화 t 세포 매개 면역반응
PL3291679T3 (pl) 2015-05-06 2022-04-25 Snipr Technologies Limited Zmiana populacji drobnoustrojowych i modyfikowanie mikrobioty
AU2016358101B2 (en) 2015-11-20 2022-12-01 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized Lymphocyte-activation gene 3
CA3020330A1 (en) * 2016-04-07 2017-10-12 Bluebird Bio, Inc. Chimeric antigen receptor t cell compositions
ES2914648T3 (es) 2016-04-08 2022-06-15 Immunocore Ltd Receptores de células T
SI3462853T1 (sl) * 2016-06-03 2023-05-31 Regeneron Pharmaceuticals, Inc. Glodavci, ki izražajo eksogeno terminalno deoksinukleotidiltransferazo
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
EP3638262A4 (en) * 2017-06-16 2021-03-24 Mayo Foundation for Medical Education and Research MATERIALS AND METHODS FOR INCREASING IMMUNE REACTION
CN111954679A (zh) 2017-10-03 2020-11-17 朱诺治疗学股份有限公司 Hpv特异性结合分子
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
KR20210029707A (ko) * 2018-04-05 2021-03-16 주노 쎄러퓨티크스 인코퍼레이티드 재조합 수용체를 발현하는 세포의 생산 방법 및 관련 조성물
EP3845638A4 (en) * 2018-07-26 2022-05-11 Kyoto University METHOD OF PRODUCTION OF A CELL DELIVERED BY A RECEPTOR GENE OF A FOREIGN ANTIGEN
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
CA3154287A1 (en) * 2019-09-12 2021-03-18 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using fusion proteins
AU2020395122A1 (en) 2019-12-02 2022-06-09 Regeneron Pharmaceuticals, Inc. Peptide-MHC II protein constructs and uses thereof
CN115485294A (zh) * 2020-03-27 2022-12-16 2赛文缇生物公司 T细胞受体
CN113684258B (zh) 2020-05-18 2024-08-20 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
AU2022249328A1 (en) 2021-03-31 2023-09-21 Regeneron Pharmaceuticals, Inc. Genetically modified mice comprising humanized cellular immune system components with improved diversity of tcrβ repertoire
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
TW202417476A (zh) 2022-08-18 2024-05-01 英商英美偌科有限公司 Ｔ細胞受體及其融合蛋白
KR20250077529A (ko) * 2022-09-22 2025-05-30 리제너론 파아마슈티컬스, 인크. 인간 세포 면역계의 성분을 발현하는, 유전자적으로 변형된 마우스
TW202520975A (zh) 2023-08-09 2025-06-01 英商劍橋企業有限公司 基因改造之囓齒動物及囓齒動物細胞以及其等用途
GB2640828A (en) 2024-04-22 2025-11-12 T Therapeutics Ltd Methods and products for the generation and identification of T cells and TCRs
GB2642411A (en) 2024-04-22 2026-01-14 T Therapeutics Ltd T Cell Receptor identification and provision

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1994006908A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Transgenic non-human animals having targeted lymphocyte transduction genes
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
WO1997032603A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6320306B1 (en) * 1996-08-05 2001-11-20 Samsung Display Devices Co., Ltd. Shadow mask with porous insulating layer and heavy metal layer
EP2305027B1 (en) 1996-12-03 2014-07-02 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
WO2001027291A1 (en) 1999-10-12 2001-04-19 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AU2002222610A1 (en) * 2000-12-13 2002-06-24 Sumitomo Pharmaceuticals Company, Limited Transgenic animal expressing hla-a24 and utilization thereof
AU2002246733B2 (en) * 2000-12-19 2007-09-20 Altor Bioscience Corporation Transgenic animals comprising a humanized immune system
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
EP1421115B1 (en) 2001-08-31 2005-03-02 Avidex Limited Soluble t cell receptor
JP4087338B2 (ja) 2001-11-15 2008-05-21 キリンファーマ株式会社 キメラ非ヒト動物
DE60106469T2 (de) * 2001-12-22 2005-10-13 4-Antbody AG Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
JP4238138B2 (ja) 2001-12-22 2009-03-11 ４−アンチボディ アーゲー 遺伝的に修飾された脊椎動物前駆体リンパ球の生成方法及び異種結合タンパク質の産生を目的としたその使用。
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
NZ539225A (en) 2002-10-09 2006-09-29 Avidex Ltd Single chain recombinant T cell receptors
AU2003279820A1 (en) * 2002-10-30 2004-06-07 The Wistar Institute Of Anatomy And Biology Mouse model for autoimmune disorders
US7663017B2 (en) * 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
CA2651174A1 (en) * 2006-05-03 2007-11-15 Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services Chimeric t cell receptors and related materials and methods of use
EP1878342A1 (en) * 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
WO2008051854A2 (en) 2006-10-20 2008-05-02 Trustees Of Boston University A tunable genetic switch for regulating gene expression
JP2008159109A (ja) 2006-12-21 2008-07-10 Matsushita Electric Ind Co Ltd データ転送装置
WO2009114400A1 (en) 2008-03-07 2009-09-17 Regeneron Pharmaceuticals, Inc. Es cell-derived mice from diploid host embryo injection
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
WO2010107400A1 (en) * 2009-03-20 2010-09-23 Agency For Science, Technology And Research Genetically modified animal and method of obtaining the same
CN102638971B (zh) * 2009-07-08 2015-10-07 科马布有限公司 动物模型及治疗分子
GB0917090D0 (en) 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
US10464987B2 (en) 2009-10-06 2019-11-05 Abbvie Inc. Human single-chain T cell receptors
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
US9557323B2 (en) 2010-09-24 2017-01-31 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
US10765093B2 (en) 2010-11-27 2020-09-08 James Zhu Humanized transgenic animal
CN114891797A (zh) * 2011-10-28 2022-08-12 瑞泽恩制药公司 T细胞受体基因修饰小鼠
KR20240132525A (ko) 2015-04-06 2024-09-03 리제너론 파아마슈티컬스, 인크. 비인간 동물에서의 인간화 t 세포 매개 면역반응

Also Published As

Publication number Publication date
KR102542272B1 (ko) 2023-06-13
JP2023024744A (ja) 2023-02-16
SMT201800553T1 (it) 2018-11-09
AU2018204700A1 (en) 2018-07-19
SI3424947T1 (sl) 2021-04-30
JP2014532413A (ja) 2014-12-08
JP7305840B2 (ja) 2023-07-10
PT2771357T (pt) 2018-11-09
KR102397961B1 (ko) 2022-05-13
JP2019033770A (ja) 2019-03-07
EP3424947A1 (en) 2019-01-09
HRP20181626T1 (hr) 2018-12-14
WO2013063361A1 (en) 2013-05-02
US20130109053A1 (en) 2013-05-02
US9113616B2 (en) 2015-08-25
CN104011071B (zh) 2017-11-07
KR102148387B1 (ko) 2020-08-26
IL305550B2 (en) 2025-02-01
BR112014009203B1 (pt) 2023-02-28
AU2012327204B2 (en) 2016-01-21
KR20210133325A (ko) 2021-11-05
IL274914B1 (en) 2023-10-01
NZ623147A (en) 2016-03-31
IL232098A0 (en) 2014-05-28
CY1123831T1 (el) 2022-05-27
IL232098B (en) 2020-06-30
JP2024019646A (ja) 2024-02-09
ES2858978T3 (es) 2021-09-30
CN104011071A (zh) 2014-08-27
RU2014121160A (ru) 2015-12-10
CA2853707A1 (en) 2013-05-02
US20220386575A1 (en) 2022-12-08
CN114891797A (zh) 2022-08-12
SG10201914043XA (en) 2020-03-30
DK3424947T3 (da) 2021-02-22
AU2021203192A1 (en) 2021-06-10
CN107858332A (zh) 2018-03-30
KR20220066197A (ko) 2022-05-23
CY1120945T1 (el) 2019-12-11
US11528895B2 (en) 2022-12-20
MX2014004894A (es) 2014-09-12
AU2018204700B2 (en) 2021-04-01
DK2771357T3 (en) 2018-10-29
ES2691475T3 (es) 2018-11-27
JP7656580B2 (ja) 2025-04-03
SI2771357T1 (sl) 2018-11-30
PL2771357T3 (pl) 2018-12-31
IL315445A (en) 2024-11-01
AU2016202512A1 (en) 2016-05-12
CN107858333A (zh) 2018-03-30
AU2021203192B2 (en) 2024-04-11
SMT202100243T1 (it) 2021-05-07
KR101964776B1 (ko) 2019-04-04
KR20190037354A (ko) 2019-04-05
JP6706311B2 (ja) 2020-06-03
HUE053444T2 (hu) 2021-06-28
IL274914B2 (en) 2024-02-01
CN114891798A (zh) 2022-08-12
US20160021856A1 (en) 2016-01-28
US20210051930A1 (en) 2021-02-25
AU2016202512C1 (en) 2018-10-11
JP6532924B2 (ja) 2019-06-19
EP3795587A1 (en) 2021-03-24
AU2018204700C1 (en) 2021-10-14
JP2020146045A (ja) 2020-09-17
JP6254528B2 (ja) 2017-12-27
PT3424947T (pt) 2021-03-01
IN2014CN03890A (es) 2015-10-16
CN107858333B (zh) 2022-05-27
BR112014009203A2 (pt) 2020-10-27
EP2771357B1 (en) 2018-07-18
CN114891798B (zh) 2025-12-02
HK1198171A1 (en) 2015-03-13
RS57893B1 (sr) 2019-01-31
PL3424947T3 (pl) 2021-06-14
AU2016202512B2 (en) 2018-03-29
AU2024204645A1 (en) 2024-08-01
JP2022093637A (ja) 2022-06-23
HRP20210256T1 (hr) 2021-04-02
EP2771357A1 (en) 2014-09-03
MX379517B (es) 2025-03-10
JP2018007696A (ja) 2018-01-18
EP3424947B1 (en) 2020-11-25
AU2012327204A1 (en) 2013-05-23
RS61455B1 (sr) 2021-03-31
SG11201401030WA (en) 2014-04-28
IL274914A (en) 2020-07-30
KR20140077219A (ko) 2014-06-23
LT3424947T (lt) 2021-03-10
KR102321909B1 (ko) 2021-11-05
LT2771357T (lt) 2018-10-25
KR20200102001A (ko) 2020-08-28
IL305550A (en) 2023-10-01
IL305550B1 (en) 2024-10-01
RU2661106C2 (ru) 2018-07-11

Similar Documents

Publication Publication Date Title
MX353134B (es) Ratones con receptor de linfocitos t modificados geneticamente.
AU2019264610A1 (en) Genetically modified animals and methods for making the same
CY1120845T1 (el) Στοχευομενη τροποποιηση γονιδιωματος αρουραιου
MX355726B (es) Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.
PH12015500213A1 (en) Production of fmdv-resistant livestock by allele substitution
MY178723A (en) Genetically modified major histocompatibility complex mice
IL252045B (en) Isolated nucleic acid, expression vector and cell culture comprising the nucleic acid
MX2012011774A (es) Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que codifican los mismos.
MX369077B (es) Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn.
BR112015001543A2 (pt) camisa de refrigeração, camisa para uma camisa de refrigeração, meio de vedação para uma camisa de refrigeração, máquina elétrica e método para produzir uma camisa de refrigeração
PH12016500342A1 (en) Non-human animals having a humanized signal-regulatory protein gene
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
EP4374690A3 (en) Mice expressing humanized t-cell co-receptors
HK1220990A1 (zh) 缺乏lincrna的非人类动物
NZ708061A (en) Methods for generating genetically superior animals
NZ758970A (en) Compositions and methods for producing genetically modified animals
MX2021001108A (es) Ratones con receptor de linfocitos t modificados geneticamente.
Galstyan The mechanism of increase of competitiveness of production of cattle breeding in theCrimea
UA46451U (ru) Способ повышения качества эмбрионов человека
NZ730667A (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Legal Events

Date Code Title Description
FG Grant or registration